Trials / Completed
CompletedNCT03761394
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
Smartwatch Monitoring for Atrial Fibrillation After Stroke
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- University of Massachusetts, Worcester · Academic / Other
- Sex
- All
- Age
- 50 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this research study is to develop a smartphone application capable of monitoring paroxysmal atrial fibrillation (pAF) in people who have survived a stroke or transient ischemic attack (TIA) or people who are at risk for a stroke and are age 50 and older. The study team plans to develop a highly effective and easy to use cardiovascular surveillance system to monitor patients for pAF on a nearly continuous basis. People involved in the development of this system include patients, their caregivers, health care providers, and computer programmers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Testing Devices | Pulsewatch system testing application on smartphone with smartwatch. |
| DEVICE | Cardea Solo by Cardiac Insight | Gold-standard cardiac monitor for comparison of testing devices. |
| DEVICE | Kardia Mobile by AliveCor | Mobile ECG device for comparison of testing devices during the extended use period. |
Timeline
- Start date
- 2019-09-03
- Primary completion
- 2021-09-20
- Completion
- 2021-09-20
- First posted
- 2018-12-03
- Last updated
- 2023-11-18
- Results posted
- 2023-11-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03761394. Inclusion in this directory is not an endorsement.